In sickle cell disease (SCD), the events originating from hemoglobin S polymerization and intravascular sickling lead to reperfusion injury, hemolysis, decreased nitric oxide (NO) bioavailability and oxidative stress. Oxidative stress is implicated as a contributing factor to multiple organ damage in SCD. We hypothesize that inhibition of sickling by genetic manipulation to enhance anti-sickling fetal hemoglobin (HbF) expression will have an ameliorating effect on oxidative stress by decreasing intravascular sickling and hemolysis and enhancing nitric oxide (NO) bioavailability. We tested this hypothesis in BERK mice expressing exclusively human α-and β S -globins and varying levels of HbF, i.e., BERK (<1% HbF), BERKγM (20% HbF) and BERKγH (40% HbF). Intravascular sickling showed a distinct decrease with increased expression of HbF, which was accompanied by decreased hemolysis and increased NO metabolites in the muscle, kidney and liver as compared with BERK mice (P<0.05-0.0001). NOx levels showed a strong inverse correlation with hemolytic rate and oxidative stress.
INTRODUCTION
Central to the vaso-occlusive pathophysiology of sickle cell disease (SCD) is polymerization of hemoglobin S (HbS) and intravascular sickling under deoxygenated conditions, the consequences of which can lead to vaso-occlusion, reperfusion injury, hemolysis, decreased nitric oxide (NO) bioavailability and oxidative stress (15; 39; 46; 48) . Oxidative stress in SCD results from hypoxia-reperfusion (vaso-occlusive events) and inactivation of anti-inflammatory nitric oxide (NO) by oxidants and plasma heme (hemolysis). Chronic oxidative stress is implicated as a critical factor in endothelial activation, inflammatory effects (e.g., higher peripheral leukocyte counts) and multiple organ damage in SCD (22) .
Since intravascular sickling is considered etiologic to the pathophysiology of SCD, attempts have been made to employ anti-sickling strategies to alleviate pathophysiology of this disease. In view of the anti-sickling properties of fetal hemoglobin (HbF), recent therapies have been designed to elevate HbF levels in sickle patients. For example, hydroxyurea has been commonly used to induce higher levels of HbF (7; 53). However, the mechanism of hydroxyurea action is somewhat controversial since hydroxyurea also results in increased NO production and thereby in decreased inflammation (i.e., diminished leukocyte counts) prior to the elevation of HbF (10) .
Recent reports suggest that hydroxyurea enhances HbF levels in sickle patients by an NO-derived mechanism (9; 10). However, it is relevant to address the issue whether genetic manipulation to increase antisickling HbF (i.e., without any pharmacological intervention) will decrease intravascular sickling, hemolysis, vaso-occlusive events (reperfusion injury) and consequently decrease oxidative stress and improve NO bioavailability.
We have previously shown that introduction of anti-sickling HbF in transgenicknockout (BERK) mice (expressing exclusively human α-and β ) generation in human SCD and transgenic sickle mice are plasma membrane NADPH oxidase (21; 57), endothelial NO synthase decoupling (2; 23), and increased plasma xanthine oxidase (4) . Our recent studies have shown that arginine supplementation of BERK mice significantly decreases lipid peroxidation and increases the activity/level of endogenous anti-oxidants secondary to enhanced NO production (13) . The availability of BERK mice expressing varying levels of HbF provides a unique opportunity to address the relationship between intravascular sickling, hemolysis, NO bioavailability and organ oxidative stress.
In the present studies, we have used BERK mice expressing >1%, 20% and 40% HbF levels (BERK, BERKγM and BERKγH mice, respectively) to resolve the following issues: 1. What is the effect of elevated HbF levels on intravascular sickling, hemolysis and NO bioavailability?; 2. Is increased NO bioavailability in HbF expressing sickle mice associated with decreased organ oxidative stress? 3. What is the relationship between intravascular hemolysis, NO bioavailability and organ oxidative stress?
In our studies, we have evaluated the effect of HbF on lipid peroxidation and selected anti-oxidants. Lipid peroxidation is implicated in cellular injury and organ damage. The first line of cellular defense against oxidative insults consists of the antioxidant superoxide dismutase (SOD) that converts O 2 .
-into H 2 O 2 , whereas the antioxidants catalase and glutathione peroxidase (GPx) convert H 2 O 2 into water.
Reduced glutathione (GSH) is the most abundant non-enzymatic antioxidant in the cell and its protective action is based on the thiol group of its cysteine, with the formation of oxidized glutathione (GSSG) (5; 14; 38).
The current study reveals that the introduction of anti-sickling HbF in BERK mice significantly alleviates oxidative stress, and this effect is mediated by anti-sickling property of HbF, which leads to increased NO bioavailability and decreased organ oxidative stress.
MATERIALS AND METHODS

Chemicals
Butylated hydroxytoluene (BHT), deferoxamine (DFO), 5,5'-dithiobis-2-nitrobenzoic acid (DTNB), glutathione (GSH), oxidized glutathione (GSSG), pyrogallol, triton X-100, ethylenediamine tetracetic acid (EDTA), bovine serum albumin (BSA), thiobarbituric acid (TBA), reduced nicotinamide adenine dinucleotide (NADH) and reduced nicotinamide adenine dinucleotide phosphate (NADPH) were obtained from Sigma/Aldrich (St. Louis, MO).
Transgenic mice
Berkeley (BERK) mice expressing cointegrated 6.4-kb miniLCR, a 1.5-kb PstI fragment of human α1 gene, and a 39-kb KpnI fragment containing human G γ A γ δ and β S globin genes were generated as described (44). These mice are homozygous for the mouse α-knockout (45) and homozygous for mouse β-knockout (52), and express exclusively human hemoglobin via the hemizygous copy of the BERK transgene (44).
Two different (-constructs generated by Gilman et al. (20) and ~40% HbF (termed BERK, BERKγM and BERKγH mice, respectively).
Hematological characteristics of these mice have been described (17; 27).
Control C57BL mice were maintained on a standard diet and water ad libitum. and had access to Nestlets (Anacare, Bellmore, NY) nesting material. All experimental protocols were approved by the institutional animal studies committee.
Measurement of globin chains
The globin composition was determined by denaturing HPLC as previously described (16) . The percent HbF was calculated as the percent of all beta-like globins.
Intravascular sickling
To determine intravascular sickling, blood samples were drawn from the tail vein into airtight syringes containing 2.5 % glutaraldehyde solution in 0.1 mol/L cacodylate buffer, pH 7.4 as described (28).
Measurement of hemolysis
For plasma free hemoglobin, blood samples were drawn from the abdominal aorta, and determinations made using a tetramethyl-benzidine-based assay kit (Catachem Inc., Bridgeport, CT) that measures plasma free hemoglobin and other heme-containing proteins present in plasma.
NO metabolites (NOx) determination
For the determination of NO metabolites, NOx, the blood was drawn from bifurcating abdominal aorta using EDTA as an anticoagulant. Total NOx concentration in plasma was determined by nitrate/nitrite colorimetric assay kit (Cayman Chemical, Ann Arbor, MI) using manufacturer's instructions (13; 29).
Preparation of homogenates, cytosol and microsome fractions
Mice were sacrificed by cervical dislocation and the entire liver was then perfused for assaying reduced glutathione. The rest of the homogenate was processed as described for the liver.
Assay methods
Lipid peroxidation (LPO). LPO in the microsomes was estimated spectrophotometrically by thiobarbituric acid reactive substances (TBARS) method, as described by Ohkawa et al.
(42) and is expressed in terms of malondialdehyde (MDA) formed per mg protein. LPO was measured using an iron chelator (DFO) and an antioxidant butylated hydroxytoluene (BHT) in the microsomal preparation as described (13) . DFO prevents further ironcatalyzed TBARS formation (6) , and BHT is used to prevent further lipid peroxidation (19). 
Glutathione (GSH
RESULTS
Hematological parameters, intravascular sickling and hemolysis. As depicted in 
Lipid peroxidation (LPO).
TBARS assay was performed in the presence of deferoxamine (DFO) and BHT to prevent further lipid peroxidation during the procedure as described in the Methods. 
Antioxidants:
Glutathione (GSH). As shown in Figure 3 , in each group of mice (n = 4-6), GSH levels were maximal in the liver followed by kidney and the muscle tissues in that order (P<0.05, multiple comparisons by ANOVA). Furthermore, for any given tissue, GSH levels were lowest in BERK mice and ~43%-65% lower than those in control C57BL 
Correlates of oxidative stress
Next, we analyzed our data to ascertain whether the decreased organ oxidative stress in HbF expressing BERK mice was a consequence of decreased hemolysis and increased NO bioavailability. As shown in Table 1 , the decrease in intravascular sickling paralleled percent HbF expression in BERKγM and BERKγH mice, and it was associated with increased hematocrit and decreased reticulocyte counts. Importantly, linear regression analysis of the data showed a strong relationship between plasma hemoglobin and plasma NOx levels as NO bioavailability increased commensurate with the decrease in plasma hemoglobin ( Figure 7A ). Similarly, a strong inverse relationship was noted when plasma NOx levels were plotted against the lipid peroxidation (LPO) values in the liver tissue ( Figure 7B ). Thus, in BERK mice (HbF, <1.0%), lowest plasma NOx values were associated with maximal lipid peroxidation; a similar relationship between NOx levels and lipid peroxidation was observed in the muscle and kidney (data not shown).
Conversely, with the introduction of anti-sickling HbF, the marked increase in NOx levels was associated with decreased lipid peroxidation.
HbF decreases peripheral leukocyte counts
To ascertain if the decrease in oxidative stress observed in the presence of HbF was associated with attenuated inflammation, we measured peripheral leukocyte counts In BERK mice, decreased NO bioavailability will contribute to oxidative stress in a manner similar to that observed after inhibiting NO synthase activity in transgenic (NY1DD) sickle mice that have mild pathology (13) . In fact, the severe pathology of BERK mice is associated with intense organ oxidative stress as evidenced by marked increase in lipid peroxidation, a marker of peroxidation of membrane lipids by peroxides, and diminished activity of antioxidants, which is in accord with our previous studies (13) .
BERK mice show 5.4 to 6.9-fold increases in lipid peroxidation in the tissues examined.
Lipid peroxidation causes damage to the cell membrane and mitochondria, and is a likely contributor to multiple organ damage in SCD. In BERK mice, depleted levels of tissue antioxidants such as GSH, total SOD, catalase and GPx will result in diminished capacity to quench oxygen radicals and thereby enhance lipid peroxidation (8; 12) . Moreover, during reperfusion (i.e., transient vaso-occlusive events), overproduction of oxygen radicals is implicated in degradation and consumption of antioxidants (40). Hence, failure to replenish antioxidants will exacerbate oxidative stress, and contribute to inflammation and multiple organ damage in SCD.
Our studies show that introduction of HbF in BERK mice resulted in marked decrease in intravascular sickling leading to recovery of hematological parameters and decreased hemolysis in BERKγM and BERKγH mice, respectively expressing 20% and 40% HbF (balance HbS). Compared with BERK mice, BERKγH mice showed >100% increase in Hct and reduced erythropoietic stress as evidenced by ~85% decrease in peripheral reticulocytes counts (see Table 1 ). Decreased sickling is likely to diminish transient vaso-occlusive events and oxidant generation. Decreased hemolysis was evident by 32% decrease in cell-free plasma hemoglobin, which will also result in decreased release of arginase that consumes arginine, the substrate of NOS (23).
Importantly, BERKγM and BERKγH mice showed a significant increase in NO metabolite (NOx) levels, which is indicative of decreased NO consumption/inactivation secondary to diminished plasma heme levels and global oxidative stress in these mice.
Although NOx values in BERKγH mice did not reach the C57BL baseline levels, the increase was 3.42-fold over the BERK values and within 75% of the C57BL levels.
In conformity with increased NO bioavailability, BERKγM and BERKγH mice showed marked, 54% to 81%, decrease in lipid peroxidation in muscle, kidney and liver tissues (see Figure 2) . In contrast to 5.4 to 6.9-fold increase in lipid peroxidation in the tissues of BERK mice over the control C57BL values, lipid peroxidation levels in BERKγH mice showed almost complete recovery to the control levels in muscle and kidney, and nearly 40% decrease in liver compared with BERK mice, demonstrating a In the present studies, we show that reduction of intravascular sickling by introduction of HbF has wide-ranging effects leading to an increase in NO bioavailability and decreased organ oxidative stress. A strong relationship between plasma NOx levels and lipid peroxidation (see Figure 7) further supports a role of NO in decreased organ oxidative stress. Decreased oxidative stress is accompanied by a significant decrease in peripheral leukocyte counts, demonstrating the anti-inflammatory effect of HbF. Thus, replenishment of NO by genetic manipulation to elevate HbF levels would result in decreased disease severity by attenuating oxidative stress and inflammation. We have previously shown that NO replenishment by arginine significantly elevates NO metabolites in transgenic-knockout sickle mice, accompanied by attenuated lipid peroxidation and enhanced activity of antioxidants (13), suggesting a role for NO in modulating oxidative stress in SCD. Future studies will be needed to examine if combining HbF elevation with arginine therapy will have a greater therapeutic effect in this disease. Nevertheless, the results of this study show that the protective effects of antisickling HbF are derived from its ability to decrease oxidative stress and enhance NO bioavailability.
Perspectives and Significance
The events originating from the primary defect of SCD (i.e., hemoglobin S polymerization and intravascular sickling) lead to multiple pathologies that include red cell abnormalities, vaso-occlusive events (reperfusion injury), and hemolysis, which contribute to increased oxidative stress and decreased NO bioavailability. Increased oxidative stress and NO deficiency in this disease are a major source of endothelial dysfunction, inflammation, vascular pathobiology and multiple organ damage. The interaction between NO and oxidative stress includes but is not limited to peroxynitrite (OONO -) formation; oxidative decoupling of endothelial nitric oxide synthase (eNOS); red cell hemolysis due to oxidative stress leading to release of arginase and the consumption of arginine, the substrate of NOS, and release of cell-free hemoglobin.
Thus, the pathophysiology of sickle cell disease is driven by both increased oxidative stress and reduced NO bioavailability. 
